{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:24:59Z","timestamp":1787235899140,"version":"build-2736575974"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic metabolic changes relevant to human immunodeficiency virus type 1 (HIV-1) infection and in response to antiretroviral therapy (ART) remain undetermined. Moreover, links between metabolic dysfunction caused by HIV and immunological inflammation in long-term treated individuals have been poorly studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Untargeted metabolomics and inflammatory cytokine levels were assessed in 47 HIV-infected individuals including 22 immunological responders (IRs) and 25 non-responders (INRs) before and after ART. The IRs and INRs were matched by age, gender, baseline viral load, and baseline CD4+T cell counts. Another 25 age-matched uninfected healthy individuals were also included as controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 770 plasma compounds detected in the current study, significant changes were identified in lipids, nucleotides, and biogenic amino acids between HIV-infected patients and healthy controls. Principal Component Analysis (PCA) and the Random Forest (RF) model suggested that levels of selected metabolites could differentiate HIV-infected patients clearly from healthy controls. However, the metabolite profiles identified in our patients were similar, and only three metabolites, maltotetraose, N, N-dimethyl-5-aminovalerate, and decadienedioic acid (C10:2-DC), were different between IRs and INRs following long-term ART. The pathway enrichment analysis results revealed that disturbances in pyrimidine metabolism, sphingolipid metabolism, and purine metabolism after HIV infection and these changes did not recover to normal levels in healthy controls even with suppressive ART. Correlation analysis of the metabolism-immune network indicated that interleukin (IL)-10, D-dimer, vascular cell adhesion molecule-1 (VCAM-1), intercellular cell adhesion molecule-1 (ICAM-1), and TNF-RII were positively correlated with most of the significantly changed lipid and amino acid metabolites but negatively correlated with metabolites in nucleotide metabolism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Significant changes in many metabolites were observed in HIV-infected individuals before and after ART regardless of their immunological recovery status. The disturbed metabolic profiles of lipids and nucleotides in HIV infection did not recover to normal levels even after long-term ART. These changes are correlated with modified cytokines and biomarkers of chronic non-AIDS events, warranting tryout of interventions other than ART.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2023.1254155","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T05:10:39Z","timestamp":1695877839000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Altered plasma metabolites and inflammatory networks in HIV-1 infected patients with different immunological responses after long-term antiretroviral therapy"],"prefix":"10.3389","volume":"14","author":[{"given":"Lianfeng","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanni","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqing","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2013.842897","article-title":"Immunodiscordant responses to HAART\u2013mechanisms and consequences","volume":"9","author":"Massanella","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13391","article-title":"Immune restoration affects 10-year survival in people living with HIV\/AIDS","volume":"24","author":"Aksak-Was","year":"2023","journal-title":"HIV Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001801","article-title":"Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa","volume":"32","author":"Kroeze","year":"2018","journal-title":"AIDS"},{"key":"B4","doi-asserted-by":"publisher","first-page":"104382","DOI":"10.1016\/j.ebiom.2022.104382","article-title":"Metabolism-dependent ferroptosis promotes mitochondrial dysfunction and inflammation in CD4+ T lymphocytes in HIV-infected immune non-responders","volume":"86","author":"Xiao","year":"2022","journal-title":"EBioMedicine"},{"key":"B5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/hiv.13247","article-title":"Longitudinal analysis of new-onset non-AIDS-defining diseases among people living with HIV: A real-world observational study","volume":"23","author":"Duan","year":"2022","journal-title":"HIV Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161920","article-title":"Plasma metabolomics biosignature according to HIV stage of infection, pace of disease progression, viremia level and immunological response to treatment","volume":"11","author":"Scarpellini","year":"2016","journal-title":"PLoS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/1471-2334-13-203","article-title":"Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors","volume":"13","author":"Cassol","year":"2013","journal-title":"BMC Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15575","article-title":"Hepatic triglyceride content is intricately associated with numerous metabolites and biochemical pathways","volume":"43","author":"Faquih","year":"2023","journal-title":"Liver Int"},{"key":"B9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12933-023-01815-6","article-title":"Cardiovascular risk of metabolically healthy obesity in two european populations: Prevention potential from a metabolomic study","volume":"22","author":"Wei","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12951-023-01908-0","article-title":"Metabolomic investigation of urinary extracellular vesicles for early detection and screening of lung cancer","volume":"21","author":"Yang","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"16947","DOI":"10.1038\/s41598-018-35271-0","article-title":"Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapy","volume":"8","author":"Peltenburg","year":"2018","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/metabo9100210","article-title":"Plasma metabolic signature and abnormalities in HIV-infected individuals on long-term successful antiretroviral therapy","volume":"9","author":"Babu","year":"2019","journal-title":"Metabolites"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3390\/v14061313","article-title":"Immunometabolic reprogramming in response to HIV infection is not fully normalized by suppressive antiretroviral therapy","volume":"14","author":"Deme","year":"2022","journal-title":"Viruses"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2018.05.001","article-title":"Plasma metabolic changes in Chinese HIV-infected patients receiving lopinavir\/ritonavir based treatment: Implications for HIV precision therapy","volume":"110","author":"Li","year":"2018","journal-title":"Cytokine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"112796","DOI":"10.1016\/j.jpba.2019.112796","article-title":"Multi-platform metabonomics unravel amino acids as markers of HIV\/combination antiretroviral therapy-induced oxidative stress","volume":"176","author":"Sitole","year":"2019","journal-title":"J Pharm BioMed Anal"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001730","article-title":"A baseline metabolomic signature is associated with immunological CD4+ T-cell recovery after 36 months of antiretroviral therapy in HIV-infected patients","volume":"32","author":"Rodriguez-Gallego","year":"2018","journal-title":"AIDS"},{"key":"B17","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1186\/s12879-021-06525-6","article-title":"The accumulation of plasma acylcarnitines are associated with poor immune recovery in HIV-infected individuals","volume":"21","author":"Qian","year":"2021","journal-title":"BMC Infect Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.04.033","article-title":"Gut bacteria metabolism impacts immune recovery in HIV-infected individuals","volume":"8","author":"Serrano-Villar","year":"2016","journal-title":"EBioMedicine"},{"key":"B19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2020.05.032","article-title":"Proteomic and metabolomic characterization of COVID-19 patient sera","volume":"182","author":"Shen","year":"2020","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-022-00193-0","article-title":"Metagenomic and metabolomic remodeling in nonagenarians and centenarians and its association with genetic and socioeconomic factors","volume":"2","author":"Xu","year":"2022","journal-title":"Nat Aging."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1053\/j.gastro.2022.06.069","article-title":"Integrated analysis of colorectal cancer reveals cross-cohort gut microbial signatures and associated serum metabolites","volume":"163","author":"Gao","year":"2022","journal-title":"Gastroenterology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.18632\/aging.100894","article-title":"Aging of immune system: Immune signature from peripheral blood lymphocyte subsets in 1068 healthy adults","volume":"8","author":"Qin","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"114986","DOI":"10.1016\/j.jpba.2022.114986","article-title":"Metabolic profiling of HIV infected individuals on an AZT-based antiretroviral treatment regimen reveals persistent oxidative stress","volume":"220","author":"Sitole","year":"2022","journal-title":"J Pharm BioMed Anal"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.885386","article-title":"Study on plasma metabolomics for HIV\/AIDS patients treated by HAART based on LC\/MS-MS","volume":"13","author":"Lao","year":"2022","journal-title":"Front Pharmacol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"119256","DOI":"10.1016\/j.saa.2020.119256","article-title":"Raman-based metabonomics unravels metabolic changes related to a first-line tenofovir-based treatment in a small cohort of South African HIV-infected patients","volume":"248","author":"Gabazana","year":"2021","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"B26","doi-asserted-by":"publisher","first-page":"103548","DOI":"10.1016\/j.ebiom.2021.103548","article-title":"Comprehensive metabolomics profiling reveals common metabolic alterations underlying the four major non-communicable diseases in treated HIV infection","volume":"71","author":"Ding","year":"2021","journal-title":"EBioMedicine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1042\/CS20190111","article-title":"Glutaminolysis and lipoproteins are key factors in late immune recovery in successfully treated HIV-infected patients","volume":"133","author":"Rosado-Sanchez","year":"2019","journal-title":"Clin Sci (Lond)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/1471-2334-11-267","article-title":"Evaluation of cardiovascular biomarkers in HIV-infected patients switching to abacavir or tenofovir based therapy","volume":"11","author":"Rasmussen","year":"2011","journal-title":"BMC Infect Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003410","article-title":"HIV infection drives pro-inflammatory immunothrombotic pathway activation and organ dysfunction among adults with sepsis in Uganda","volume":"37","author":"Cummings","year":"2023","journal-title":"AIDS"},{"key":"B31","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3390\/v14050997","article-title":"Differences in expression of selected interleukins in HIV-infected subjects undergoing antiretroviral therapy","volume":"14","author":"Szymanska","year":"2022","journal-title":"Viruses"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1177\/095632020101200301","article-title":"Cytokines and HIV-1: interactions and clinical implications","volume":"12","author":"Kedzierska","year":"2001","journal-title":"Antivir Chem Chemother"},{"key":"B33","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s12916-022-02700-x","article-title":"Distinct metabolic biomarkers to distinguish IgG4-related disease from Sjogren's syndrome and pancreatic cancer and predict disease prognosis","volume":"20","author":"Yan","year":"2022","journal-title":"BMC Med"},{"key":"B34","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04435-22","article-title":"Transport and utilization of glycogen breakdown products by Gardnerella spp. from the human vaginal microbiome","volume":"11","author":"Bhandari","year":"2023","journal-title":"Microbiol Spectr"},{"key":"B35","doi-asserted-by":"crossref","DOI":"10.1128\/jb.00393-22","article-title":"Glycogen-Degrading Activities of Catalytic Domains of alpha-Amylase and alpha-Amylase-Pullulanase Enzymes Conserved in Gardnerella spp. from the Vaginal Microbiome","volume":"205","author":"Bhandari","year":"2023","journal-title":"J Bacteriol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12916-021-02035-z","article-title":"Salivary metabolites associated with a 5-year tooth loss identified in a population-based setting","volume":"19","author":"Andorfer","year":"2021","journal-title":"BMC Med"},{"key":"B37","article-title":"Assessment of coverage for endogenous metabolites and exogenous chemical compounds using an untargeted metabolomics platform","volume":"25","author":"Kong","year":"2020","journal-title":"Pac Symp Biocomput"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1254155\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T05:10:43Z","timestamp":1695877843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1254155\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2023.1254155"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1254155","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,27]]},"article-number":"1254155"}}